As per MRFR analysis, the MRI Systems Devices Market Size was estimated at 6.52 (USD Billion) in 2023.
The MRI Systems Devices Market Industry is expected to grow from 6.77(USD Billion) in 2024 to 10.3 (USD Billion) by 2035. The MRI Systems Devices Market CAGR (growth rate) is expected to be around 3.88% during the forecast period (2025 - 2035).
Several significant trends are now impacting the MRI Systems Devices Market. Driven by the rising incidence of chronic illnesses and the need for precise diagnoses, one notable trend is the expanding use of sophisticated imaging technology, particularly in developing countries. Increasing healthcare costs in many nations are helping hospitals and clinics buy innovative MRI equipment, hence supporting the movement toward more common use. Key market drivers also include improved image quality and quicker scan times, which motivate operators to modernize current systems to better satisfy patient demand.
Furthermore, the field of portable MRI equipment offers many possibilities to be investigated as they fit the growing need for point-of-care imaging solutions. Advances in technology are leading to smaller, more economical MRI equipment that will provide easier access in distant locations and enhance diagnosis in under-equipped medical institutions. Latest trends include the incorporation of artificial intelligence into MRI equipment, which seeks to simplify procedures and increase diagnostic accuracy. By means of dedicated support tools, this not only improves the quality of patient care but also helps radiologists.
There is also a major emphasis on sustainability, which inspires companies to investigate eco-friendly materials and manufacturing techniques. As world health authorities prioritize patient experience, the movement toward patient-centric designs, which seek to improve comfort and lower anxiety during scans, is also a crucial component. Driven by innovation and changing healthcare demands, the confluence of these developments places the MRI Systems Devices Market in a position for ongoing expansion.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising incidence of chronic diseases especially cancer and neurological disorders is a major factor in the Global Magnetic Resonance Imaging (MRI) Systems Devices Market. Data from the World Health Organization (WHO) indicates that during the next two decades, cancer incidence is likely to increase by around 70%, with the number of new cases forecasted to reach 29.5 million by 2040. This disturbing number underlines the pressing necessity of sophisticated imaging technology, including MRI scanners, to support early diagnosis and treatment planning.
Major healthcare institutions like the American Cancer Society are driving the need for complex imaging technologies by stressing the need for early diagnosis. Furthermore, efficient patient care is increasingly dependent on MRI technological developments, such as functional MRI and MRI-guided treatments, which will help the MRI Systems Devices Market Industry.
Technological developments in MRI systems significantly drive the expansion of the MRI Systems Devices Market. High-field MRI systems and portable MRI equipment are examples of innovations that have greatly improved image quality and hence enabled more precise and rapid diagnosis of complicated diseases. The Radiological Society of North America reports that more and more MRI equipment is being fitted with 3 Tesla magnets, which improves picture quality and speeds up scanning.
These developments not only enhance patient outcomes but also help healthcare professionals run more efficiently. Leading manufacturers such as Siemens Healthineers and GE Healthcare are at the forefront of these technical developments, significantly changing the market scene and creating new benchmarks for MRI performance.
One major engine of the MRI Systems Devices Market is the increase in healthcare spending worldwide. Emphasizing the need for sophisticated diagnostic technologies, governments, and commercial enterprises are raising their healthcare spending. The World Bank reports that nations spent a record 9.8% of their GDP on healthcare in 2022, indicating that global health expenditures have been rising. This trend shows the growing cost and accessibility of diagnostic tools like MRI.
For instance, nations like Germany and the United States are well recognized for their large healthcare expenditures, which guarantees that the most current MRI equipment is available in their healthcare institutions. Increasing financial commitment from this source enables healthcare providers to buy sophisticated MRI equipment, hence supporting the market expansion.
The MRI Systems Devices Market Application segment is a vital component of the overall industry, expected to further expand as healthcare demands increase. In 2024, the Application segment will significantly contribute to the market, with Diagnostic Imaging valued at 2.5 USD Billion, showcasing its majority holding due to the increasing necessity for accurate disease diagnoses. The Functional Imaging component is projected to reach 1.5 USD Billion, playing a crucial role in assessing brain function and other physiological processes, which underlines its importance in neuroscientific research and clinical practices. Cardiac Imaging, valued at 1.25 USD Billion in 2024, is becoming increasingly significant given the rise in cardiovascular diseases globally, providing detailed imagery that supports timely and precise interventions. Meanwhile, Oncology Imaging, valued at 1.52 USD Billion, demonstrates its significance in oncological assessments, especially with the increasing burden of cancer cases worldwide.
By 2035, these values are expected to grow, solidifying their importance in the healthcare sector, with Diagnostic Imaging anticipated to reach 3.75 USD Billion, Functional Imaging to 2.25 USD Billion, Cardiac Imaging to 1.8 USD Billion, and Oncology Imaging to 2.5 USD Billion. This growth trajectory illustrates the rising reliance on MRI technology across various applications, addressing crucial needs in diagnostics and treatment planning. The MRI Systems Devices Market revenue reflects an evolving landscape influenced by advancements in technology, patient needs, and a growing emphasis on preventive healthcare. The segment's statistics are crucial for stakeholders, providing them with necessary data to understand market trends and allocate resources effectively. Furthermore, the ongoing improvements in MRI technology, coupled with increasing adoption in emerging economies, are likely to drive innovation and enhance patient outcomes, making the Application segment a critical area of focus in the overall MRI Systems Devices Market landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The MRI Systems Devices Market is projected to reach a valuation of 6.77 USD Billion by 2024, enhancing its relevance in the healthcare sector. Within this market, the Type segmentation comprises Closed MRI Systems, Open MRI Systems, and Extremity MRI Systems, each contributing uniquely to the overall industry dynamics. Closed MRI Systems are known for their high-resolution imaging and are often favored in clinical practices for their reliability. Open MRI Systems provide a patient-friendly alternative, addressing fears of claustrophobia and expanding accessibility for patients unable to use traditional machines. Extremity MRI Systems, while less common, serve a vital role in diagnosing specific limb-related conditions, emphasizing forthright imaging for extremities without the need for full-body scans. The growing demand for diagnostic imaging, coupled with technological advancements in these systems, is propelling market growth. Furthermore, trends like personalized medicine and an increasing emphasis on non-invasive diagnostic techniques are shaping the future landscape of the MRI Systems Devices Market. However, challenges such as high costs and maintenance requirements persist alongside opportunities to innovate in imaging technology. As such, the market exhibits diverse potentials to cater to a wide array of healthcare needs globally.
The MRI Systems Devices Market is witnessing substantial growth driven by advancements in technology and increased healthcare expenditure. By 2024, the market is valued at 6.77 billion USD, with robust expansion expected to continue thereafter. Within the Field Strength category, various types of MRI systems, notably Low Field, Mid Field, and High Field MRI, play pivotal roles in diagnostics. Low Field MRI is often used in specific applications where high penetration of tissues is required and cost-effectiveness is a priority. Mid Field MRI systems provide a balanced approach, offering sufficient image clarity while being less expensive than high-end alternatives. High Field MRI systems dominate the market due to their exceptional detail and precision in imaging, which is critical for complex cases. The segmentation of the MRI Systems Devices Market highlights the diversity in technology, enabling tailored solutions for different clinical needs. The pressing demand for imaging systems, supported by aging populations and rising chronic diseases globally, further fuels market growth. Factors such as these underscore the importance and significance of each field strength category in enhancing patient care and diagnostic accuracy in the healthcare industry.
The MRI Systems Devices Market is characterized by a robust segmentation focused on End Users, primarily comprising Hospitals, Diagnostic Imaging Centers, and Research Institutes. By 2024, the overall market is expected to be valued at 6.77 USD Billion, reflecting a steady growth trajectory fueled by increasing healthcare demands and advancements in imaging technology. Hospitals remain a crucial contributor to this market, as they account for a significant portion of MRI utilization, driven by the rising prevalence of chronic diseases requiring detailed imaging. Diagnostic Imaging Centers are also pivotal, providing specialized services that cater to outpatient needs and enhancing access to MRI technologies. Research Institutes play an essential role, contributing to innovation and advancements in MRI technologies, which pave the way for enhanced diagnostic capabilities. The MRI Systems Devices Market growth is bolstered by several factors, including a surge in the aging population needing imaging diagnostics and advances in MRI technologies that improve safety and effectiveness. However, challenges such as high costs and procedural complexities may hinder market expansion. Nevertheless, opportunities lie in expanding access to these devices and increasing awareness among healthcare professionals, ensuring that all segments are equipped to handle the growing demand for MRI diagnostic capabilities.
The MRI Systems Devices Market shows a robust structure across various regions, with North America leading in market revenue, valued at 2.7 USD Billion in 2024 and projected to reach 4.05 USD Billion by 2035. This region's dominance is attributed to advanced healthcare infrastructure and significant investment in healthcare technology. Europe follows closely with a valuation of 1.8 USD Billion in 2024, rising to 2.73 USD Billion in 2035, benefiting from a strong regulatory framework and increasing healthcare expenditure. The APAC region accounts for 1.5 USD Billion in 2024, expected to grow to 2.25 USD Billion by 2035, driven by rising demand for medical imaging and improving healthcare access. South America, although smaller in market size with 0.53 USD Billion in 2024 and 0.79 USD Billion in 2035, is experiencing growth due to increasing health awareness and technological adoption. Meanwhile, the MEA region is valued at 0.24 USD Billion in 2024 and anticipated to reach 0.36 USD Billion by 2035, with growth influenced by investment in healthcare facilities and rising populations. Collectively, these regions reflect the diverse opportunities and growth trends within the MRI Systems Devices Market landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The MRI Systems Devices Market is characterized by a diverse array of companies that contribute to the development, manufacturing, and distribution of MRI technology, which is crucial for various medical diagnostics and research applications. As healthcare demands evolve with technological advancements, the competitive landscape in this market is becoming increasingly dynamic. Companies are focusing on innovation to enhance imaging quality, improve patient comfort, and reduce scan times, which are critical for gaining a competitive edge. Furthermore, the integration of artificial intelligence and machine learning into MRI systems is creating significant opportunities for businesses to differentiate themselves and capture larger market shares. The competitive insights of this market reveal a strong emphasis on strategic collaborations, research investments, and the expansion of product portfolios to address diverse healthcare requirements globally.
Esaote stands out in the MRI Systems Devices Market due to its commitment to innovation and specialization. The company has established a notable presence by focusing on ultrasound and MRI solutions tailored for specific clinical applications, which positions it favorably against more generalized competitors. Esaote's strengths include its dedicated research and development efforts aimed at advancing MRI technology to improve diagnostics and treatment workflows. This focus has led to the introduction of compact and efficient MRI systems that are both cost-effective and technologically advanced. With a global reach, Esaote has cultivated strong relationships with healthcare providers, enhancing its distribution capabilities and reinforcing its market position.
Hologic plays a significant role in the MRI Systems Devices Market by offering a broad range of diagnostic imaging solutions, particularly focusing on women's health. The company is recognized for its high-quality products and innovative technology, contributing to its strong reputation in the healthcare industry. Hologic’s MRI systems are designed to deliver precise imaging, which is critical in various clinical settings, particularly for breast imaging applications. The company's strengths lie in its research-driven approach and continuous improvements in imaging technology. Hologic has strategically pursued mergers and acquisitions to expand its product lineup and technological capabilities, which further solidifies its market presence. Through these initiatives, Hologic aims to improve patient outcomes and enhance operational efficiencies in healthcare settings across the globe.
The MRI Systems Devices Market has seen significant developments recently, with a strong focus on technological advancements and market expansion. Companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare have been enhancing their product lines with advanced imaging technologies and artificial intelligence integration. In September 2023, Fujifilm Holdings launched a new MRI system aimed at improving diagnostic capabilities in oncology, showcasing the continual innovation within the sector.
Furthermore, in July 2023, Mindray announced an increase in its market share due to its recent focus on affordable and high-quality MRI devices, contributing to its valuation growth. Additionally, major players like United Imaging Healthcare are expanding their operations in emerging markets, significantly impacting the overall market dynamics. On the mergers and acquisitions front, Bracco Imaging was involved in an acquisition deal in August 2023 to expand its technological capabilities and product portfolio, with notable backing.
The market is witnessing tailored solutions becoming more prevalent, reflecting the changing needs of healthcare providers worldwide, which is further accelerated by post-pandemic recovery efforts. As a result, the MRI Systems Devices Market is experiencing substantial growth, driven by innovation and strategic business maneuvers among leading companies.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 0.8(USD Billion) |
| MARKET SIZE 2024 | 0.88(USD Billion) |
| MARKET SIZE 2035 | 2.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.93% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Pfizer, Merck and Co, AbbVie, Roche, Eli Lilly, Johnson and Johnson, UCB, Teva Pharmaceutical Industries, Novartis, Celgene, Astellas Pharma, BristolMyers Squibb, GlaxoSmithKline, Amgen, Sanofi |
| SEGMENTS COVERED | Treatment Type, Diagnosis Method, End User, Disease Severity, Regional |
| KEY MARKET OPPORTUNITIES | Rising prevalence of autoimmune disorders, Advancements in diagnostic technologies, Increased awareness and education, Growth in biologic therapy options, Expanding telehealth services for management |
| KEY MARKET DYNAMICS | Rising prevalence of autoimmune disorders, Increasing geriatric population, Growing awareness of treatment options, Advancements in diagnostic technologies, Enhanced pharmaceutical developments |
| COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
Sacroiliitis Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Sacroiliitis Market is expected to be valued at 0.88 billion USD in 2024.
By 2035, the Global Sacroiliitis Market is projected to reach a value of 2.5 billion USD.
The expected CAGR for the Global Sacroiliitis Market from 2025 to 2035 is 9.93%.
In 2024, North America holds the largest market share at 0.36 billion USD.
North America is projected to reach a market value of 1.04 billion USD by 2035.
The market size for Medication treatment in the Global Sacroiliitis Market is expected to be 1.25 billion USD by 2035.
The market value of Physical Therapy in 2024 is estimated to be 0.24 billion USD.
Major players include Pfizer, Merck and Co., AbbVie, Roche, and Eli Lilly.
The expected market value for the Surgery treatment type in 2035 is 0.45 billion USD.
By 2035, South America is expected to reach a market size of 0.2 billion USD.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
